Second Global School of Translational Science |
The Second Global School of Translational Science is driven by the study of diseases whose incidence rose dramatically with the increase in the life expectancy of the population. Cancer and neurodegenerative conditions, such as Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis and diseases caused by prions, still incurable, represent a major problem for society and should drain a lot of resources over the next 20 years.
The goal of the school is to provide a setting for discussion of molecular medicine, from basics to translational aspects, both in cancer and in neurodegenerative diseases. The program has added some of the leading experts in the field of basic research and treatment, in an environment that favors learning and exchange of cutting-edge information in the area.
-
Institution
Hospital A C Camargo. Fundação Antonio Prudente
-
Field of Knowledge
Medicine
-
Academic Director
Vilma Regina Martins
-
Grant Number
2011/50125-9
-
Date
2011-06-19 to 2011-06-24
-
Registration Deadline
closed
-
Site
-
City
São Paulo
-
Keywords
Cancer, pain, memory
-
Program
Hide
Organizing Committee
Vilma R. Martins - A.C. Camargo Hospital, São Paulo, Brazil
Marco A.M. Prado- Robarts Research Institute and University of Western Ontario, Ontario, Canada
Glaucia Hajj - A.C. Camargo Hospital, São Paulo, Brazil
Sergio Ferreira- Federal University of Rio de Janeiro, Rio de Janeiro
Stephen Ferguson- Robarts Research Institute and University of Western Ontario, Ontario, Canada
Marc G. Caron - Duke University Medical Center, Durham, North Caroline, USA
June 19th - Day 1
9:30- 9:45 – Vilma R. Martins & Marco Antonio M. Prado
Opening remarks
9:45- 10:15 –Carlos Henrique de Brito Cruz
Introducing FAPESP
10:15- 10:45 - Ricardo R. Brentani
Introducing the AC Camargo Hospital and the National Institutes of Science and technology
11:00 – 12:00
Opening conference – Don Cleveland (University of California USCF / Ludwig Institute for Cancer Research)
Guarding the genome: aneuploidy and tumorigenesis
12:00 – 14:00 - Lunch
Membrane and cell signaling compartmentalization
14:00 – 15:00 Jay T Groves (University of California/ HHMI)
Mechanisms of signal transduction in cell membranes
15:00- 16:00 John D Scott (Washington School of Medicine/HHMI)
Cell Signaling in Space and Time
16:00 - 16:30 Coffee break
16:30 - 17:30 – Marc Caron (Duke University)
Brain Monoamines/GPCR Systems: New approaches for CNS disorder therapies?
18:00 – 20:00 - Welcome Cocktail
June 20th - Day 2
Molecular Mechanisms in pain
8:30-9:30 - Michael Salter (SickKids Research Institute)
Exploring neuron-microglia signaling in pain plasticity
9:30-10:30 - Terrance Snutch (Brain Research Centre, Canada)
Novel agents targeting voltage-gated calcium and sodium channels for pain intervention
10:30-11:00 - Coffee break
11:00-12:00- Marcus Vinicius Gomez (Federal University of Minas Gerais, Brazil)Brazilian toxins targeting channels involved in pain
12:00 – 14:00 - Lunch
Brain, development and Synaptic Plasticity
14:00-15:00 - Roberto Lent (Federal University of Rio de Janeiro, Brazil)
Developmental plasticity in the cerebral cortex of mice and men
15:00 – 16:00 - John MacDonald (Robarts Research Institute, Canada)
TRPing from NMDA receptors to Stroke and Alzheimer’s Dementia: Dysregulation of non-selective cation channels and changes in excitatory synaptic transmission in the hippocampus.
16:00 – 16:30 - Coffee break
16:30- 17:30 Student presentation
17:30-18:30 Meet the expert Happy hour (The idea of these meetings is o give a more informal atmosphere for students to talk with the invited speakers).
June 21th day 03
Genome and transcriptome
8:30-9:30 - Silvia Rogatto (A.C. Camargo Hospital)
Molecular approaches to identify biological markers of response to chemotherapy in cancer patients.
9:30-10:30 – Dirce M Carraro (A.C. Camargo Hospital)
Deciphering the transcriptome of breast cancer
10:30-11:00 - Coffee break
11:00- 12:00 Emmanuel Dias-Neto (A.C. Camargo Hospital)
miRNA regulatory networks
12:00-14:00 - Lunch
Drug discovery in diseases
14:00-15:00 – Robert Hegele (Robarts Research Institute, Canada)
Genomic architecture of complex human metabolic disease
15:00-16:00 – Elena Pasquale (Stanford-Burnham Medical Research Institute)
Emerging Strategies to Target the Eph Receptor Family of Receptor Tyrosine Kinases for Disease Therapy
16:00-16:30 - Coffee break
16:30- 17:30 – Guido J.R. Zaman (Merck, Sharp & Dohme)
Drug Discovery process in general (assay development, high-throughput screening, structural biology and lead optimization).
17:30- 18:30 – Meet the expert Happy hour
June 22rd - Day 4
Cellular signaling in brain development and cognition
8:30- 9:30 - Martin Cammarota (Catholic University of Rio Grande do Sul, Brazil)
On dopamine, BDNF and retrieval...and other factors controlling memory persistence
9:30- 10:30 - Ivan Izquierdo (Catholic University of Rio Grande do Sul, Brazil)
Why some consolidated memories last for a couple of days and others last for a lifetime
10:30 -11:00 – Coffee break and poster
11:00-12:00 - Eric Klann (New York University Center for Neural Science)
Translational control: Molecules, synapses, behavior, and neurological disorders
12:00-14:00 – Lunch
Cellular signaling and Neurotransmitter systems
14:00-15:00 - Vania Prado (Robarts Research Institute, Canada)
Mouse models of cholinergic hypofunction: novel tales of an old neurotransmitter
15:00-16:00 - Fernando Mello (Federal University of Rio de Janeiro, Brazil)
Müller cells in identity crisis: To be or not to be a dopaminergic neuron
16:00-16:30 – Coffee break and poster
16:30-17:30- Esper Cavalheiro (Federal University of São Paulo)
Epileptogenesis and antiepileptogenesis: an experimental approach
17:30- 18:30 - Meet the expert -Happy hour
(The idea of these meetings is o give a more informal atmosphere for students to talk with the invited speakers).
June 23rd-5 day
Molecular pathology and new therapeutic candidates
8:30- 9:30 – Fernando A. Soares (A.C. Camargo Hospital)
Connecting traditional morphology with molecular pathology: the pathway to new tumor classification
9:30-10:30 – Vilma R. Martins (A.C. Camargo Hospital)
Prion protein signaling in Glioblastomas: a new therapeutic approach?
10:30 -11:00 Coffee break
11:00-12:00 – Rafael Linden (Federal University of Rio de Janeiro, Brazil)
Subcellular localization of transcription factors: Target for neuroprotective gene therapy and implications for Neurosciences and Oncology
12:00-14:00 - Lunch
Post translational modifications and cellular stress
14:00-15:00 - Ronald Hay (University of Dundee, UK)
Molecular basis for arsenic trioxide therapy in Acute Promyelocytic Leukemia
15:00-16:00 - Bradly Wouters (University Heath Network, Toronto)
Cellular responses to the tumor microenvironment and their importance in cancer
16:00-16:30 Coffee break
16:30-17:30 Gabriela Chiosis (Memorial Sloan-Kettering Cancer Center)
Modulation of heat shock proteins as a therapeutic approach in cancer and neurodegenerative diseases
17:30-18:30 Selected student presentation
June 24th - Day 6
Neurodegenerative diseases
8:30- 9:30 - William Klein (Northwestern University, Illinois)
Molecular basis for the cause, diagnosis and treatment of Alzheimer’s disease
9:30- 10:30 - Marco Prado (Robarts Research Institute, Canada)
STI1-Prion protein complex as a potential target in Alzheimer’s and Prion diseases
10:30 -11:00 – Coffee break
11:00 – 12:00 – Sergio Ferreira (Federal University of Rio de Janeiro, Brazil)
Aβ oligomers, synaptic plasticity and mechanisms of pathogenesis in Alzheimer’s disease
12:00-14:00 - Lunch
Neurodegenerative/neurological diseases
14:00-15:00 - Glaucia Hajj (A. C. Camargo Hospital)
The control of protein synthesis in Prion and Alzheimer Diseases
15:00-16:00 - Stephen Ferguson (Robarts Research Institute, Canada)
Role of Desensitization and Endocytosis in the Regulation of G protein-coupled Receptor Signaling in neurodegenerative and neuropsychiatric diseases
16:00-16:30 – Coffee break
Closing lecture
16:30-17:30- Don Cleveland (University of California USCF/Ludwig Institute for Cancer Research)
From Charcot to Lou Gehrig: mechanisms and therapy in Amyotrophic Lateral Sclerosis
17:30-18:00 Closing remarks
20:00 Farewell dinner